GlassScriptPhysician profile
Grace O Hassan
NPI 1396044012
$7,501.20
in general payments reported to CMS, 2019-2025
27 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 89% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,780 · 2022: $997 · 2023: $2,190 · 2024: $1,364 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,277 · Travel and Lodging: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,276.66 |
| Travel and Lodging | $447.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,962.57 | 2021-2025 | Proclaim, Prodigy |
| Abbvie INC. | $1,234.58 | 2021-2025 | |
| Relievant Medsystems, INC. | $1,052.65 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $819.94 | 2021-2025 | Xtampza, Belbuca |
| Pfizer INC. | $589.25 | 2021-2025 | |
| Boston Scientific Corporation | $303.02 | 2021-2025 | Intracept, Varithena Administration Pack |
| Teva Pharmaceuticals USA, INC. | $260.07 | 2021-2025 | Austedo, Austedo Xr, Austedo Xr |
| Biohaven Pharmaceuticals, INC. | $180.91 | 2021 | |
| Amgen INC. | $170.30 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $162.08 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $144.85 | 2022 | |
| Vertos Medical, INC. | $76.86 | 2023-2024 | Mild Device Kit |
| Averitas Pharma INC. | $70.27 | 2023-2025 | Qutenza |
| Curonix LLC | $68.89 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $65.84 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $53.72 | 2024-2025 | Ha Minuteman G3-R |
| Lundbeck LLC | $41.40 | 2023 | Vyepti |
| Convatec INC. | $37.11 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.84 | 2021 | |
| Allergan, INC. | $29.70 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $29.17 | 2024 | |
| Lilly USA, LLC | $27.87 | 2021 | |
| Protega Pharmaceutials INC | $24.63 | 2025 | Roxybond |
| Medtronic, INC. | $18.16 | 2025 | Venaseal |
| Tonix Medicines, INC. | $17.15 | 2025 | Tonmya |
| Redhill Biopharma INC. | $14.50 | 2021 | |
| Biotronik Nro, INC. | $13.87 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.